Trust isn’t your most valuable asset —your brand recognition is. In the pharmaceutical world, that recognition is built through years of research, regulatory compliance, and reputation. But it can disappear in an instant. If you operate in this industry, you already know how complex it has become. Across Mexico and Latin America, counterfeiting and unauthorized trade are growing faster than traditional control measures can keep up. According to the World Health Organization, one in ten medicines sold in low- and middle-income countries is falsified or substandard. In Mexico, COFEPRIS reported over 3,000 irregular products in 2023, many of them with packaging and serial codes nearly identical to the originals. What’s most concerning isn’t just the scale of the issue —it’s how invisible it has become. Even formal distribution chains can be deceived. The rise of e-commerce has multiplied that risk. Digital marketplaces, social media, and online pharmacies have become the new breeding ground for fake products disguised as legitimate. The BrandShield 2024 report uncovered over 7,500 fake pharmaceutical ads active online last year. Each one doesn’t just steal revenue —it erodes the trust patients, doctors, and distributors have in your name. ...
Read more
